The Role of Molecular Markers in Endometrial Cancer: An Overview of the Important Markers

Abstract

Cancer markers could be described as expressed molecular products by Neoplasia tissues or metabolized and secreted by tumors. Tumor markers can be identified biochemically in the body’s fluids like blood or urine. Cancer markers could be used as a means to supervise the patient’s response to treatment or the prediction of relapse, progress, or metastases, or even the survival of the patient. In recent years, due to an increase in obesity life expectancy in cancer cases, specifically endometrial cancer has risen dramatically. By researching and investigating cancer markers, a day could be envisioned when all types of cancers could be detected through a simple blood test, treated and millions of lives could be saved annually. Through biological methods to identify new markers of diagnosing cancer, over the past decades, many studies have been done on cancer markers. By using this data and its clinical applications, accurate diagnosis could be reached, patients could be alerted of the possibility of the disease and help them get cured. In this study, we have looked at cancer markers to diagnose, Prognosis, and monitor endometrial cancer.